Laurion Capital Management LP Rapt Therapeutics, Inc. Transaction History

Laurion Capital Management LP

  • $7.27 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$29.86 - $39.47 $1.78 Million - $2.35 Million
-59,459 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$17.99 - $40.02 $1.07 Million - $2.38 Million
59,459 New
59,459 $1.89 Million
Q4 2020

Feb 12, 2021
SELL
$15.89 - $40.87 $317,800 - $817,400
-20,000 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$21.6 - $37.5 $432,000 - $750,000
20,000 New
20,000 $644,000

Others Institutions Holding RAPT

# of Institutions
104
Shares Held
27.1M
Call Options Held
26.7K
Put Options Held
2.4K
View Full List

About RAPT Therapeutics, Inc.

RAPT Quotes by TradingView
  • Ticker RAPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,656,600
  • Market Cap $35.6M
  • Description
  • RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...
More about RAPT
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email